Hospital-acquired C. diff comes with a financial price tag

The average healthcare cost for patients with the C. diff infection was $43,718


A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.

In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.

The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.

The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.

Read the article.



August 5, 2019


Topic Area: Infection Control


Recent Posts

EaaS: Funding Infrastructure Projects with Energy Savings

Process converts necessary upgrades from capital liabilities into strategic investments using operational dollars.


Balancing Security Systems with Patient Comfort in Healthcare

Security systems, safety and inviting atmospheres don’t have to be in conflict.


Harris Health Reports 10-Year Data Breach

Their investigation determined that the impermissible access to patient information occurred between January 4, 2011, and March 8, 2021.


Gen Z Trusts AI More Than Their Managers

Some employees would rather engage with AI than their managers.


CISA Lapse Amid Government Shutdown Raises Concerns for Healthcare Cybersecurity

Lawmakers had sought to renew it for another decade, but disagreements in the Senate stalled reauthorization.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.